PHOTO-MICROPATTERNING FOR ELECTRON MICROSCOPY
20220301810 · 2022-09-22
Inventors
- Julia MAHAMID (Heidelberg, DE)
- Mauricio TORO-NAHUELPAN (Nussloch, DE)
- Laurent BLANCHOIN (Grenoble, FR)
Cpc classification
International classification
Abstract
The invention relates to electron microscopy (EM) supports for in situ cryo-electron tomography, particularly to contactless and mask-free photo-micropatterning of EM grids for site-specific deposition of extracellular matrix-related proteins for micromachining by cryo-focused ion beam milling. The new EM supports allow for analysis of intracellular organization, permitting direct correlation of cell biology and biomechanics by 3D-structural characterization of the underlying molecular machinery in cellulo.
Claims
1. A functionalized electron microscopy support comprising at least one or several area(s) functionalized with a substrate allowing for the adhesion of a biological specimen, particularly a living cell, wherein the functionalized area(s) is/are at least partially or is completely surrounded by at least passivation layer substance, wherein said substance at least partially repels live cells and/or does not allow for, or at least partially reduces the adhesion of live cells.
2. The functionalized electron microscopy support according to claim 1, wherein the electron microscopy support is an electron microscopy grid, particularly comprising or consisting of gold, copper, molybdenum, titanium or platinum.
3. The functionalized electron microscopy support according to claim 1 or 2, wherein said electron microscopy support optionally comprises a biocompatible film, preferably a SiO2-, graphene, carbon-, gold-film, or silicon nitride (Si.sub.3N.sub.4), particularly a SiO2-film.
4. The functionalized electron microscopy support according to any one of claims 1 to 3, wherein the passivation layer substance comprises a repelling agent, particularly wherein the repelling agent comprises a polyether, polyethylene glycol, and/or poly(L-lysine)-grafted-poly(ethylene glycol) (PLL-g-PEG).
5. The functionalized electron microscopy support according to any one of claims 1 to 4, wherein the substrate for the adhesion of live cells comprises proteins, glycoproteins, and/or polysaccharides, particularly wherein the substrate for the adhesion of live cells comprises at least one extracellular matrix component selected from the group comprising laminin, fibronectin, vitronectin, integrin, collagen, fibrillin, elastine, and glycosaminoglycane, Arginylglycylaspartic acid (RGD) peptides, and Arginylglycylaspartic acid (RGD)-conjugated chemicals or proteins.
6. The functionalized electron microscopy support according to any one of claims 1 to 5, further comprising at least one living cell or fixed cell in at least one area.
7. A method of preparing the functionalized electron microscopy support as defined in any one of claims 1 to 6, said method comprising: a) Providing an electron microscopy support, b) Coating said electron microscopy support with a passivation layer substance, particularly wherein said substance at least partially repels live cells and/or does not allow for, or at least partially reduces the adhesion of live cells, c) Photo-micropatterning said coated electron microscopy support obtained in b).
8. The method according to claim 7, wherein the photo-micropatterning step is a contactless and/or mask-free photo-micropatterning step, particularly wherein the photo-micropatterning step locally removes the passivation layer substance of step b) to provide areas which are essentially free of passivation layer substances.
9. The method according to any one of claims 7 or 8, wherein the photo-micropatterning step is performed with a pulse laser, particularly with a 300 nm to 370 nm pulse laser, more particularly with a 355 nm pulse laser, or said step is performed by UV-illumination with a digital micro-mirror device (DMD).
10. The method according to any one of claims 7 to 9, further comprising a step d) comprising functionalizing with substrate allowing for the adhesion of live cells in those areas where the photo-micropatterning step removed the passivation layer substance applied in step b).
11. The method according to any one of claims 7 to 10, wherein the passivation layer substance comprises a repelling agent, particularly wherein the repelling agent comprises a polyether, particularly polyethylene glycol or poly(L-lysine)-grafted-poly(ethylene glycol) (PLL-g-PEG).
12. The method according to any one of claims 7 to 11, said method further comprising step e), wherein at least one living cell is seeded in at least one area functionalized with a substrate allowing for the adhesion of live cells.
13. The method according to any one of claims 7 to 12, wherein the substrate for the adhesion of live cells comprises proteins, glycoproteins, polysaccharides.
14. The method according to any one of claims 7 to 13, said method further comprising step e), wherein the living cell is fixed or vitrified to the support.
15. Use of functionalized electron microscopy support as defined in any one of claims 1 to 6, or of an functionalized electron microscopy support prepared in a method according to any one of claims 7 to 14 in the analysis of biomolecules or of adherent cells, particularly comprising at least one method selected from the group comprising microscopy, confocal microscopy, vitrification, cryo-FIB milling, transmission electron microscopy, cryo-light microscopy, cryo-electron tomography, cryo-focused ion beam (FIB) analysis, cryo-correlative light-electron microscopy (Cryo-CLEM), and/or cellular micromachining by cryo-FIB milling.
16. A method for producing a circuit of cells, comprising the steps of: a) Providing a functionalized electron microscopy support according to any one of claims 1 to 6, or a functionalized electron microscopy support prepared in a method according to any one of claims 7 to 14, b) Providing at least two cells, and c) Seeding said cells in at least one area of said electron microscopy support functionalized with a substrate allowing for the adhesion of said cells, thereby generating the circuit of cells on the electron microscopy support.
17. The method according to claim 16, wherein the cells are selected from neurons, hepatocytes, myocytes, cardiomyocytes, stem cells, stem cell progenitor cells, trophoblasts, astrocytes, glial cells, enterocytes, hepatic cells, kidney cells, endothelial cells, epithelial cells, such as biliary epithelial cells, syncytiotrophoblasts, cytotrophoblasts, mesenchymal cells, inner cochlea cells, outer cochlea cells, trophoblasts, preferably wherein the cells are human cells, such as human neurons.
18. The method according to claim 16 or 17, wherein said cells belong to the same cell type or to at least two different cell types.
19. A circuit of cells produced by a method according to any one of claims 16 to 18.
20. A circuit of cells according to claim 19 for use in medicine.
21. A circuit of cells according to claim 19 for use in the treatment and/or prevention of a brain disease, spinal-cord injury, a heart disease, liver failure, kidney failure, deafness, a degenerative disease, such as a neurodegenerative disease, and/or a skin disease, or in the manufacture of a medicament against a brain disease, spinal-cord injury, a heart disease, liver failure, kidney failure, deafness, a degenerative disease, such as a neurodegenerative disease, and/or a skin disease.
22. Use of a circuit of cells according to claim 19 to repair at least one damaged circuit in or on the human body, for example to repair a damaged neuronal circuit.
23. A method of treatment and/or prevention of a brain disease, spinal-cord injury, a heart disease, liver failure, kidney failure, deafness, a degenerative disease, such as a neurodegenerative disease, and/or a skin disease in a subject, the method comprising the step of administering to the subject a circuit of cells according to claim 19.
24. The method according to claim 23, wherein said subject is a mammal, such as a human, a mouse, rat, guinea pig, rabbit, cat, dog, monkey, preferably a human, for example a human patient, more preferably a human patient suffering from a brain disease, spinal-cord injury, a heart disease, liver failure, kidney failure, deafness, a degenerative disease, such as a neurodegenerative disease, and/or a skin disease.
Description
DESCRIPTION OF THE FIGURES
[0111]
[0112]
[0113]
[0114]
[0115]
[0116]
[0117]
[0118]
[0119]
[0120]
[0121]
[0122]
EXAMPLES
[0123] Certain aspects and embodiments of the invention will now be illustrated by way of example and with reference to the description, figures and tables set out herein. Such examples of the methods, uses and other aspects of the present invention are representative only, and should not be taken to limit the scope of the present invention to only such representative examples.
Example 1: Micropatterning of Functionalized Electron Microscopy Support
[0124] In order to perform the present invention contactless and mask-free photo-micropatterning were adapted (
[0125] HeLa cells are a prominent model system in cell biology, and must be thinned to reveal structures positioned deep in their interior by cryo-ET. We seeded HeLa cells on fibronectin-functionalized micropatterned (30 μm disk-shape) grids. A reproducible seeding of single or double cells at the center of individual grid squares was achieved (
[0126] Next, complex patterns to control cell shape were generated. Micropatterning on glass surfaces has been previously shown to induce well-defined cytoskeletal architectures and, as a result, a stereotypical internal organization of cellular organelles.sup.Refs. 8,9.
[0127] Here, the actin network in Retinal pigment epithelium cells (RPE) as a case of study and as a direct readout of the cellular response to adhesion on the complex patterns will be described. Tailored micropatterns induced reproducible cell morphology on grids (
[0128] To explore the organization of the cytoskeleton further away from the cell peripheries and to characterize spatially-predictable structures according to live-cell actin maps (
[0129] In conclusion, photo-micropatterning of EM grids contributes to the advancement of refined, routine and user-friendly specimen preparations for in-cell structural biology. It further aids in solving technical challenges that have, thus far, hindered high-throughput FIB thinning preparations. This method will be instrumental for potential automation of the cryo-FIB milling process, deeply impacting the streamlining state-of-the-art cellular cryo-EM pipelines. This approach offers a unique opportunity to generate in-cell integrated insight into the structure and dynamics of macromolecules at nanometer-scale, broadening the scope of questions that can be addressed by state-of-the-art structural biology methods.
[0130] Methods
[0131] Cell Lines and Culture
[0132] Wild type HeLa Kyoto cells, and a double tagged line expressing both green fluorescent protein (GFP)-tagged β-tubulin from a bacterial artificial chromosome (BAC) and mCherry tagged histone from a plasmid construct (H2B-mCherry). HeLa cells were cultured in Dulbecco's modified Eagle's medium (DMEM; ThermoFischer Scientific, Schwerte, Germany), while RPE-1 (Retinal Pigment Epithelial human cells) expressing LifeAct-GFP19 were cultured in DMEM F-12. Cells were incubated at 37° C. with 5% CO2, and supplemented with 10% (v/v) fetal bovine serum (FBS), 2 mM L-glutamine, 100 mg/mL penicillin, 100 mg/mL streptomycin. A 0.5 mg/mL geneticin (G418) for the BAC-tagged lines and Puromycin (1 μg/ml) for cells carrying the plasmids were used. FluoroBrite DMEM (ThermoFischer Scientific, Schwerte, Germany) was used for live cell fluorescence imaging.
[0133] Electron Microscopy Grids
[0134] Gold (Au) or Titanium (Ti) 200-mesh grids with a holey 12 nm thick SiO2 film, either R2/1, R1/4 or R1/20 (Quantifoil Micro Tools, Jena, Germany) were employed in this study. Titanium-mesh grids, and SiO2 films replacing the commonly used amorphous carbon Quantifoil, provided stiffer and more robust supports for the multiple grid processing and cell culture steps described in the method. Both, titanium (
[0135] Increased amount of film over holes promoted better cell adhesion. R2/1 and R1/4 films were advantageous for direct tomography of peripheral cellular areas, while R1/20 and R1/4 films were more suitable for cellular thinning by cryo-FIB milling as the majority of the film is removed during thinning.
[0136] Grid Passivation
[0137] One-step: Grids were oxidized and rendered hydrophilic using a low-pressure Diener Femto Plasma cleaner. Grids were place onto a glass slide and both sides were plasma cleaned at 100 W power with a flow rate 10 cm3/min of oxygen gas for 30-40 s. Next, grids were incubated on droplets of poly(l-lysine) grafted with poly(ethylene glycol) (PLL(20)-g[3.5]-PEG(5), SuSoS AG, Dübendorf, Switzerland) at a concentration of 0.5 mg/ml in 10 mM Hepes pH 7.4, for 1 h at room temperature or overnight at 4° C., on a parafilm in a humid chamber (parafilm sealed dish with soaked filter paper). Following passivation, the grids were blotted with filter paper from the side and allowed to dry. No washing of the PLL-Peg was performed.
[0138] Two-step: As an alternative, a two-step treatment of the grids was also tested. First, grids were incubated on droplets of 0.01% PLL (Sigma Aldrich, St. Louis, Mo.) on a parafilm in a humid chamber overnight at room temperature. Next, the grids were blotted, but not allowed to dry and incubated for 1-2 h with 50 mg/ml PEG-sva (Laysan Bio, Arab, US).
[0139] Both passivation protocols were successful for grid passivation followed by photo-micropatterning, as judged from fluorescence light microscopy imaging of GFP-absorption that was restricted to the PEG-free patterns. However, a one-step PLL-g-PEG passivation was preferred for time optimization purposes. This treatment is especially convenient in the absence of plasma cleaner and can be used following the more commonly employed glow discharge procedures.
[0140] Micropatterns were designed in Inkscape (http://www.inkscape.org/) as 8-bit binary files and exported as png files, which can be loaded into the Leonardo software (Alveolé Lab, Paris, France).
[0141] Micropatterning and Functionalization of Grids
[0142] Nanoablation by a 355 nm Pulse Laser
[0143] An inverted confocal Olympus FluoView 1200 (Olympus, Hamburg, Germany) microscope was used, equipped with a UV pulsed laser source of 355 nm (PNV-001525-140, Teem Photonics, Meylan, France), a UPLSAPO 63× (NA 1.35) oil objective, and a standard PMT or GaAsP PMT detectors. The 355 nm laser had an average power of 50 mW, 300 ps pulse width, 1 kHz repetition rate, and a maximum energy per pulse of 20 μJ. Transmission and reflection were observed with a 488 nm laser. The patterns (ROIs) were of circular shape (20, 30 or 40 μm diameter) and made using the Olympus FV 10-ASW software v04.02.03.02. Photo-micropatterning was performed using 10-11% laser power, 40 82 s per pixel and 10 iterations. Individual grid squares were targeted at a time, the film focused and the laser applied. Micropatterning of a 4×4 grid square area (200-mesh grid: ˜260,000 μm2) took ˜8 min. Potentially, a lower magnification objective can be used in order to pattern more grid squares at the same time in order to optimize patterning, provided that the film is flat and at even height to maintain all areas in the focus plane. Titanium grids had a consistent film flatness aiding quick focusing on each grid square, facilitating the micropatterning using this technique.
[0144] PRIMO™ (DMD-Based Illumination+Photo-Activator):
[0145] An inverted Nikon microscope Ti-E equipped with a CFI Super Plan FLuor 20× ELWD (NA 0.45) lens with high UV-transmission, a Perfect Focus System 3, an ORCA-Flash 4.0 LT CMOS camera (Hamamatsu, Japan), a motorized stage (Märzhäuser, Wetzlar, Germany), and the Primo™ micropatterning module (Alveolé Lab, Paris, France) was used. Grid micropatterning was performed using digital mirror device (DMD) to generate a spatially controlled laser illumination of the sample (Primo™, Alveolé Lab, Paris, France), which provides a resolution limit of ˜1.2 μm. After passivation with PLL-g-PEG, grids were blot-dried from the back with a filter paper and quickly placed with the SiO2 film facing up (away from the objective) on a 1-3 μl of PLPP (4-benzoylbenzyl-trimethylammonium chloride, 14.5 mg/ml) drop in a sealed glass bottom ibidi μ-Dish 35 mm low (ThermoFischer Scientific, Schwerte, Germany). High humidity was kept using water-soaked filter paper inside the dish to avoid PLPP evaporation. The dish, with 1-4 grids at a time, was placed on the microscope stage and photo-patterning was controlled with the μmanager software v1.4.22 by the Leonardo plugin software v4.12 (Alvéole Lab, Paris, France) using the stitching mode and a 375 nm (4.5 mW) laser, applying a dose of 800-1000 mJ/mm.sup.2 equivalent to ˜30 s per DMD exposition. Micropatterning of an 8×7 grid square area (200-mesh grid: ˜900,000 μm2) took 3-7 min depending on the total dose and grid positioning with respect to the DMD mirror illumination. Grids were promptly retrieved from the PLPP solution, washed in a 300 μl drop of water, and two consecutive washes in 300 μl drops of PBS. Grids were stored wet in PBS at 4° C. in a humid chamber, remaining functional for at least 30 days.
[0146] For functionalization following PEG ablation in micropatterns using both methods, grids were incubated at room temperature in a 20 μl drop of either 50 μg/ml fibronectin (ThermoFischer Scientific, Schwerte, Germany), a 50 μg/ml of a GFP-tagged protein, or 50 μg/ml of fibrinogen-488 (ThermoFischer Scientific, Schwerte, Germany) on a parafilm and, subsequently, washed 3 times in 300 μl drops of PBS. Grids incubated with fibronectin remain functional for at least to 10 days in PBS at 4° C. in a humid chamber. The maximum active life time of the micropatterned grids as well as protein functionalization remain unknown. This will also depend on the protein stability itself. All patterning steps and grid treatments were performed under sterile conditions using a Bunsen burner. Grids were handled with a tweezer n° 55 (Dumont, Montignez, Switzerland).
[0147] Comparison Between the Two Patterning Approaches:
[0148] Due to the pulsing nature of the laser in the first approach, it has to scan the region of interest to be patterned to ablate the anti-fouling agent. The action of the laser leaves an impression on the film that is visible by light microscopy (
[0149] While the Primo device takes 30 s per DMD run (for a dose of 1000 mJ/mm.sup.2 and covering a 3×2 grid squares on a 200-mesh grid), the 355 nm-pulse laser patterning takes ˜10-15 s per grid square considering a disk-shaped pattern of 20-30 μm diameter. A user familiar with the 355 nm laser technique can pattern a 4×4 grid square area in ˜8 min, while the Primo technology covers a similar area in ˜1 min. While the Primo device is faster to create micropatterned areas, the 355 nm-pulse scanning laser can yield a much higher spatial lateral resolution limited by the light diffraction (PSF) and equivalent to ˜250 nm, in comparison to the Primo performance that is limited to ˜1.5 μm.
[0150] At least 50 grids have been seeded with either HeLa or RPE cells obtaining reproducible results with cells settling and adhering to the micropatterned areas.
[0151] Cell Seeding
[0152] Non-patterned grids were plasma cleaned or glow discharged. Cells were detached from cell culture flasks using 0.05% trypsin-EDTA and seeded on pre-treated Quantifoil grids in glass bottom ibidi μ-Dish 35mm high (ThermoFischer Scientific, Schwerte, Germany).
[0153] Cells were seeded on fibronectin micropatterned surfaces right after being passed through a cell 40 μm pore-size cell strainer (Corning, Amsterdam, Netherlands) at a density of 2×10.sup.4 cells/cm.sup.2 for HeLa and 8×10.sup.3 cells/cm.sup.2 for RPE cell lines. After seeding, grids were incubated for 1.5-2 h for HeLa cells or 20-35 min RPE cells. Next, cells were transferred to a new cell-free dish and incubated at 37° C. with 5% CO2 to allow adhesion to the grids. Transfer to a new dish was beneficial to remove cells that were non-specifically attached to areas outside the patterns. Cells were vitrified 4-6 h post-transfer for RPE cells (to attain a higher number of individual grid squares with a single cell) or after overnight incubation for HeLa cells.
[0154] Live Cell Confocal Imaging
[0155] Time lapse imaging of HeLa cells on grids (
[0156] Zeiss Airyscan microscopy
[0157] AiryScan microscopy of RPE cells on patterned grids (
[0158] Widefield Microscopy Imaging
[0159] Epifluorescence images (
[0160] Vitrification
[0161] Grids were blotted from the reverse and immediately plunged into a liquid ethane or ethane/propane mixture at liquid nitrogen temperature using a Leica EM GP plunger (Leica Microsystems, Vienna, Austria). The plunger was set to 37° C., 99% humidity, and blot time of 2 s for R2/1, and 2.5 s for R1/4 and R1/20 grids. The frozen grids were stored in sealed boxes in liquid nitrogen until further processing.
[0162] Cryo-Scanning Electron Microscopy and Focused Ion Beam Milling
[0163] Cryo-FIB lamella preparations were performed as described in Ref. 5, on a dedicated dual-beam microscope with a cryo-transfer system and a cryo-stage (Aquilos, ThermoFisher Scientific, Brno, Czech Republic). Plunge frozen grids were fixed into autogrids modified for FIB preparation (Max Planck Institute of Biochemistry, Martinsried, Germany), mounted into a shuttle (ThermoFisher Scientific) and transferred into the dual-beam microscope through a load-lock system. During FIB operation, samples were kept at constant liquid nitrogen temperature using an open nitrogen-circuit, 360° rotatable cryo-stage. To improve sample conductivity and reduce curtaining artifacts during FIB milling, the samples were first sputter-coated with platinum (10 mA, 20 s) and then coated with organometallic platinum using the in situ gas injection system (GIS, ThermoFisher Scientific, Netherlands) operated at room temperature, 10.6 mm stage working distance and 7 s gas injection time. Appropriate positions for FIB preparations were identified and recorded in the MAPS 3.3 software (ThermoFisher Scientific, Brno, Czech republic), and eucentric height refined per position. Lamellae or wedges were prepared using Gallium ion beam at 30 kV at stage tilt angles of 20° for lamellae and 12°-13° for wedges. Lamella or wedge preparations were conducted in a stepwise rough milling, starting with high currents of 1 nA, 5 □m away from the area of interest, gradually reduced to lower currents, down to 50 pA for the final cleaning steps. Progress of the milling process was monitored using the scanning electron beam operated at 10 kV and 50 pA (or 2 kV for visualization of micropatterns). For improved conductivity of the final lamella for specimens intended for phase plate tomography, we again sputter coated the grid after cryo-FIB preparation with platinum (10 mA, 3 s). Grids were stored in sealed boxes in liquid nitrogen until further processing.
[0164] Cryo-Electron Tomography
[0165] Cryo-electron microscopy data were collected on a Titan Krios microscope operated at 300 kV (ThermoFisher Scientific, Netherlands) equipped with a field-emission gun, a Quantum post-column energy filter (Gatan, Pleasanton, Calif., USA), a K2 Summit direct detector camera (Gatan) and a Volta phase plate (ThermoFisher Scientific, Netherlands). Data were recorded in dose-fractionation mode using acquisition procedures in SerialEM software v3.7.2.sup.Ref. 21. Prior to the acquisition of tilt-series, montages of the entire lamella were acquired at ˜2 nm/pix. Tilt-series using a dose symmetric scheme were collected in nano-probe mode, EFTEM magnification 42,000× corresponding to pixel size at the specimen level of 3.37 Å, 3-4 μm defocus, tilt increment 2° with constant dose for all tilts, total dose ˜120 e−/Å2. The pre-tilt of lamellae with respect to the grid plane due to cryo-FIB milling at shallow angles (10-15°) was corrected for by tilting the stage on the microscope. Conventional tilt-series, Volta phase plate (VPP), were acquired at the same settings with an objective aperture and a beam tilt of 4 mrad for autofocusing (tomograms in
[0166] Data Processing
[0167] Prior to tilt-series alignment, the projection movies were corrected for beam induced drift in the SerialEM plugin. Tilt series alignment and tomographic reconstructions were performed using the IMOD software package, version 4.9.0.sup.Ref. 21. In absence of fiducial gold nanoparticles in the FIB-lamellae, alignment of tilt-series images was performed with patch-tracking. Final alignment of the tilt-series images was performed using the linear interpolation option in IMOD without CTF correction. Aligned images were binned to the final pixel size of 13.48 Å. For tomographic reconstruction, the radial filter options were left at their default values (cut off, 0.35; fall off, 0.05). Tomograms from
[0168] Photo-Micropatterning by a 355 Nanoablation UV-Laser
[0169] The inventors used a second method of photo-micropatterning by ablating the PLL-g-PEG passivation layer in a spatially-control manner using a 355 nm-pulse laser setup (see methods). Due to the pulsing nature of the laser, it has to scan the region of interest to be patterned to ablate the anti-fouling agent. The action of the laser leaves an impression on the film that is visible by light microscopy (
Example 2: Design of a Human Neural Network on a Chip
[0170] The inventors developed a method for producing a circuit of cells, comprising the functionalized electron microscopy support according to this invention, and at least two cells. The circuit of cells can, for example, grow on a device, such as a chip. Said cells can be neurons, hepatocytes, myocytes, cardiomyocytes, stem cells, stem cell progenitor cells, trophoblasts, astrocytes, glial cells, enterocytes, hepatic cells, kidney cells, endothelial cells, epithelial cells, such as biliary epithelial cells, syncytiotrophoblasts, cytotrophoblasts, mesenchymal cells, inner cochlea cells, outer cochlea cells, and/or trophoblasts. As a proof of principle, the inventors developed a human neural network growing on a functionalized electron microscopy support according to this invention (
[0171] The micropattern was coated with laminin protein for human neuron adherence, and grids were seeded with induced human stem cells and differentiated to neurons (day-6 post seeding) on a grid. Human neurons can be observed by fluorescence microscopy due to a soluble protein (Ngn2-GFP) spread across the cells. Neurons are observed following the micropatterned circuit (
REFERENCES
[0172] The references are: [0173] 1. Kalbrandt, W. Science 343, 1443-1444 (2014). doi:10.1126/science.1251652 [0174] 2. Pfeffer, S. & Mahamid, J. Curr Opin Struct Biol 52, 111-118 (2018). doi:10.1016/j.sbi.2018.08.009 [0175] 3. Beck, M. & Baumeister, W. Trends Cell Biol 26, 825-837 (2016). doi:10.1016/j.tcb.2016.08.006 [0176] 4. Mahamid, J. et al. Science 351, 969-972 (2016). doi:10.1126/science.aad8857 [0177] 5. Schaffer, M. et al. J Struct Biol 197, 73-82 (2017). doi:10.1016/j.jsb.2016.07.010 [0178] 6. Rigort, A. et al. Proc Natl Acad Sci USA 109, 4449-4454 (2012). doi:10.1073/pnas.1201333109 [0179] 7. Dubochet, J. & Sartori Blanc, N. Micron 32, 91-99 (2001) [0180] 8. Azioune, A., Carpi, N., Tseng, Q., Thery, M. & Piel, M. Methods Cell Biol 97, 133-146 (2010). doi:10.1016/50091-679X(10)97008-8 [0181] 9. Thery, M. J Cell Sci 123, 4201-4213 (2010). doi:10.1242/jcs.075150 [0182] 10. Strale, P. O. et al. Adv Mater 28, 2024-2029 (2016). doi:10.1002/adma.201504154 [0183] 11. Thery, M., Jimenez-Dalmaroni, A., Racine, V., Bornens, M. & Julicher, F. Nature 447, 493-496 (2007). doi:10.1038/nature05786 [0184] 12. Thery, M. et al. Nat Cell Biol 7, 947-953 (2005). doi:10.1038/ncb1307 [0185] 13. Arnold, J. et al. Biophys J 110, 860-869 (2016). doi:10.1016/j.bpj.2015.10.053 [0186] 14. Engel, L. et al. Preprint at https://doi.org/10.1101/657072 (2019). [0187] 15. Thery, M. et al. Proc Natl Acad Sci USA 103, 19771-19776 (2006). doi:10.1073/pnas.0609267103 [0188] 16. Senger, F. et al. Preprint at http://dx.doi.org/10.1101/578799 (2019). [0189] 17. Jasnin, M. et al. Proc Natl Acad Sci USA 110, 20521-20526 (2013). doi:10.1073/pnas.1320155110 [0190] 18. Jasnin, M. & Crevenna, A. H. Biophys J 110, 817-826 (2016). doi:10.1016/j.bpj.2015.07.053 [0191] 19. Vignaud, T. et al. J Cell Sci 125, 2134-2140 (2012). doi:10.1242/jcs.104901 [0192] 20. Rigort, A. et al. J Struct Biol 172, 169-179 (2010). doi:DOI 10.1016/j.jsb.2010.02.011 [0193] 21. Kremer, J. R., Mastronarde, D. N. & McIntosh, J. R. J Struct Biol 116, 71-76 (1996). doi:http://dx.doi.org/10.1006/jsbi.1996.0013 [0194] 22. Fukuda, Y., Laugks, U., Lucic, V., Baumeister, W. & Danev, R. J Struct Biol 190, 143-154 (2015). doi:DOI 10.1016/j.jsb.2015.03.004 [0195] 23. Politi, A. Z. et al. Nat Protoc 13, 1445-1464 (2018). doi:10.1038/nprot.2018.040 [0196] 24. Schindelin, J. et al. Nat Methods 9, 676-682 (2012). doi:10.1038/nmeth.2019